Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis

Immunity

Volumn 8, Issue 5, 1998, Pages 615-623

  Refaeli, Yosef ^a   Van Parijs, Luk ^b   London, Cheryl A ^a   Tschopp, Jürg ^c   Abbas, Abul K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; FAS ANTIGEN; FAS LIGAND; FLIP INHIBITOR PROTEIN; INHIBITOR PROTEIN; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

EID: 17544398702     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80566-X     Document Type: Article

References (40)

1. Boise, L.H., and Thompson, C. (1997). Bcl-xL can inhibit apoptosis in cellsthat have undergone Fas-induced protease activation. Proc. Natl. Acad. Sci. USA 94, 3759-3764.
2. Boldin, M.P., Varfolomeev, E.E., Pancer, Z., Mett, I.L, Camonis, J.H., and Wallach, D. (1995). A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270, 7795-7798.
3. Boldin, M.P., Goncharov, T.M., Golstev, Y.V., and Wallach, D. (1996). Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1 and TNFreceptor-induced cell death. Cell 85, 803-815.
4. Brunner, T., Mogil, R.J., LaFace, D., Yoo, N.J., Mahboubl, A., Echeverri, F., Martin, S.J., Force, W.R., Lynch, D.H., Ware, C.F., and Green, D.R. (1995). Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373, 441-444.
5. Chinnaiyan, A.M., O'Rourke, K., Tewari, M., and Dixit, V.M. (1995). FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505-512.
6. Chinnaiyan, A.M., O'Rourke, K., Lane, B.R., and Dixit, V.M. (1997). Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science 275, 1122-1126.
7. Combadiere, B., Freedman, M., Chen, L., Shores, E.W., Love, P., and Lenardo, M.J. (1996). Qualitative and quantitative contributions of the T cell receptor zeta chain to mature T cell apoptosis. J. Exp. Med. 183, 2109-2117.
8. Dhein, J., Walczak, H., Baümler, C., Debatin, K.M., and Krammer, P.H. (1995). Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373, 438-441.
9. Fisher, G.H., Rosenberg, F.J., Strauss, S.E., Dale, J.K., Middleton, L.A., Lin, A.Y., Strober, W., Lenardo, M.J., and Puck, J.M. (1995). Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune syndrome. Cell 81, 935-946.
10. Fournel, S., Genestier, L., Robinet, E., Flacher, M., and Revillard, J.P. (1996). Human T cells require IL-2 but not G1/S transition to acquire susceptibility to Fas-mediated apoptosis. J. Immunol. 157, 4309-4315.
11. Golstev, Y.V., Kovalenko, A.V., Arnold, E., Vafolomeev, E.E., Brodianskii, V.M., and Wallach, D. (1997). CASH, a novel caspase homologue with death effector domains. J. Biol. Chem. 272, 19641-19644.
12. Hahne, M., Peitsch, M.C., Irmler, M., Schröter, M., Lowin, B., Rousseau, M., Bron, C., Renno, T., French, L., and Tschopp, J. (1995). Characterization of the non-functional Fas ligand of gld mice. Int. Immunol. 7, 1381-1386.
13. Hu, S., Vicenz, C., Ni, J., Genz, R., and Dixit, V.M. (1997). I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1-and CD95-induced apoptosis. J. Biol. Chem. 272, 17255-17257.
14. Irmler, M., Thome, M., Hahne, M., Schneider,P., Hofman, K.,Steiner, V., Bodmer, J.L., Schröter, M., Burns, K., Mattmann, C., et al. (1997). Inhibition of death receptor signals by cellular FLIP. Nature 388, 190-195.
15. Ju, ST., Panka, D.J., Cui, H., Ettinger, R., E-Khatbl, M., Sherr, D.H., Stanger, B.Z., and Marshack-Rothstein, A. (1995). Fas(CD95)/FasL Interactions required for programmed cell death after T-cell activation. Nature 373, 444-448.
16. Kneitz, B., Herman, T., Yonehara, S., and Schimpl, A. (1995). Normal clonal expansion but impaired Fas-mediated cell death and anergy in IL-2 deficient mice. Eur. J. Immunol. 25, 2572-2577.
17. Latinis, K.M., Carr, L.L., Peterson, E.J., Norian, L.A., Eliason, S.L., and Koretzky, G.A. (1997). Regulation of CD95 (Fas) Ligand expression by TCR-mediated signaling events. J. Immunol. 158, 4602-4611.
18. Lenardo, M.J. (1991). Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353, 858-861.
19. Lin, J.-X., Migone, T.S., Tsang, M., Friedmann, M., Weatherbee, J.A., Zhou, L., Yamauchi, A., Bloom, E.T., Meitz, J., Johns, S., et al. (1995). The role of shared receptor motifs and common Stat proteins in the generation of cytokinepleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13 and IL-15. Immunity 2, 331-339.
20. Muzio, M., Chinayan, A.M., Kischel, F.C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J.D., Zhang, M., Gentz, R., et al. (1996). FLICE, a novel FADD-homologous ICE/CED-3-like protease , is recruited to the CD95 (Fas/APO-1 ) death-inducing signaling complex. Cell 85, 817-827.
21. Nagata, S. (1997). Apoptosis by death factor. Cell 88, 355-365.
22. Nagata, S., and Suda, T. (1995). Fas and Fas ligand: lpr and gld mutations, Immunol. Today 16, 39-43.
23. Nakajima, H., Liu, X.W., Wynshaw-Boris, A., Rosenthal, L.A., Finbloom, D.S., Hennighausen, L., and Leonard, W.J. (1997): An indirect effect of Stat5a in IL-2-induced proliferation: a critical rolefor Stat5a in IL-2-mediated IL-2 receptor alpha chain induction. Immunity 5, 691-701.
24. Pear, W.S., Nolan, G.P., Scott, M.L., and Baltimore, D. (1993). Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90, 8392-8396.
25. Peter, M.E., Kischkel, F.C., Sheuerpflug, G.G., Medema, J.P., Debatin, K.M., and Krammer, P.H. (1997). Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex. Eur. J. Immunol. 27, 1207-1212.
26. Rieux-Laucat, F., LeDeist, F., Hivroz, C., Roberts, I.A., Debatin, K.M., Fisher, A., and de Villartay, J.P. (1995). Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347-1349.
27. Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A.C., and Horak, I. (1993). Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75, 253-261.
28. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, Second Edition (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press).
29. Shu, H.B., Halpin, D.R., and Goeddel, D.V. (1997). Casper is a FADD-and caspase-related inducer of apoptosis. Immunity 6, 751-763.
30. Srinivasula, S.M., Ahmad,M., Ottilie, S., Bullrich, F., Banks, S., Wang, Y., Fernandez-Alnemri, T., Croce, C.M., Litwack, G., Tomaselli, K.L., et al. (1997). FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J. Biol. Chem. 272, 18542-18545.
31. Stanger, B.Z., Leder, P., Lee, T.H., Kim, E., and Seed, B. (1995). RIP: a novel protein containing a death domain that interacts with Fas/ APO-1 (CD95) in yeast and causes cell death. Cell 81, 513-523.
32. Susin, S.A., Zamzami, N., Castedo, M., Douglas, E., Wang, H.G., Geley, S., Fassy, F., Reed, J.C., and Kroemer, G. (1997). The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95-and ceramide-induced apoptosis. J. Exp. Med. 186, 25-37.
33. Suzuki, H., Kunding, T.M., Furlonger, C., Wakeman, A., Timms, E., Matsuyama, T., Schmitts, T., Simard, J., Ohashi, P.S., Greisser, H., et al. (1995). Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268, 1472-1476.
34. Thome, M., Schneider, P., Hofman, K., Fickenscher, H., Meinl, E., Neipel, F., Mattmann, C., Burns, K., Bodmer, J.L., Schröter, M., et al. (1997). Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 356, 517-521.
35. Van Parijs, L., Ibraghimov, A., and Abbas, A.K. (1996). Role of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4, 321-328.
36. Van Parijs, L., Biuckians, A., Ibraghimov, A., Alt, F.W., Willerford, D., and Abbas, A.K. (1997). Functional responses and apoptosis in CD25 (IL-2Ra)-deficient lymphocytes expressing a transgenic antigen receptor. J. Immunol. 158, 3738-3745.
37. Van Parijs, L., Biuckians, A., and Abbas, A.K. (1998). Fas and Bcl-2 regulate distinct pathways of apoptosis in T lymphocytes. J. Immunol. 160, 2065-2071.
38. Vander Heiden, M.G., Chandel, N.S., Williamson, E.K., Schumacher, P.T., and Thompson, C.B. (1997). Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91, 627-637.
39. Willerford, D.M., Chen, J., Ferry, J.A., Davidson, L., Ma, A., and Alt, F.W. (1995). Interleukin-2 receptor a chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3, 521-530.
40. Zheng, L., Trageser, C.L., Willerford, D.M., and Lenardo, M.J. (1998). T cell growth cytokines cause the superinduction of molecules mediating antigen-induced T lymphocyte death. J. Immunol. 160, 763-769.